世衛(wèi)報(bào)告充分肯定中醫(yī)藥抗疫貢獻(xiàn)

Traditional Chinese medicines are beneficial in the treatment of COVID-19, particularly mild to moderate cases, according to a new report released by the World Health Organization.

世界衛(wèi)生組織日前發(fā)布的一份新報(bào)告指出，中醫(yī)藥能有效治療新冠肺炎，對(duì)輕型和普通型病例尤其有效。

It also encourages member states to consider the potential use of TCM for the management of COVID-19 in the context of their healthcare systems and regulatory frameworks.
世衛(wèi)組織鼓勵(lì)會(huì)員國(guó)在其衛(wèi)生保健系統(tǒng)和監(jiān)管框架內(nèi)考慮使用中醫(yī)藥治療新冠肺炎的可能性。

The report came in late March after a WHO Expert Meeting on Evaluation of TCMs in the Treatment of COVID-19 was held virtually from Feb 28 to March 2.
世衛(wèi)組織中醫(yī)藥救治新冠肺炎專家評(píng)估會(huì)于2月28日至3月2日以視頻會(huì)議形式召開(kāi)。

The meeting gathered 21 international experts from the six WHO regions to consider three reports, including on clinical service, research and evidence-based evaluation provided by national expert groups in China.
來(lái)自世衛(wèi)組織6個(gè)地區(qū)辦事處的21名國(guó)際專家圍繞臨床實(shí)踐、科學(xué)研究和循證評(píng)價(jià)等方面展開(kāi)研討，對(duì)中方專家分享的關(guān)于中醫(yī)藥救治新冠肺炎相關(guān)報(bào)告進(jìn)行了交流和評(píng)估，并于3月底形成專家評(píng)估會(huì)報(bào)告。